Foghorn Therapeutics (FHTX) Asset Utilization Ratio: 2020-2025
Historic Asset Utilization Ratio for Foghorn Therapeutics (FHTX) over the last 5 years, with Sep 2025 value amounting to 0.11.
- Foghorn Therapeutics' Asset Utilization Ratio rose 41.95% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year increase of 41.95%. This contributed to the annual value of 0.08 for FY2024, which is 19.79% down from last year.
- According to the latest figures from Q3 2025, Foghorn Therapeutics' Asset Utilization Ratio is 0.11, which was up 14.07% from 0.10 recorded in Q2 2025.
- In the past 5 years, Foghorn Therapeutics' Asset Utilization Ratio ranged from a high of 0.13 in Q1 2024 and a low of 0.00 during Q1 2021.
- In the last 3 years, Foghorn Therapeutics' Asset Utilization Ratio had a median value of 0.10 in 2025 and averaged 0.09.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 2,960.69% in 2021, then plummeted by 33.04% in 2024.
- Quarterly analysis of 5 years shows Foghorn Therapeutics' Asset Utilization Ratio stood at 0.00 in 2021, then surged by 1,126.68% to 0.05 in 2022, then skyrocketed by 148.61% to 0.11 in 2023, then slumped by 33.04% to 0.08 in 2024, then skyrocketed by 41.95% to 0.11 in 2025.
- Its Asset Utilization Ratio stands at 0.11 for Q3 2025, versus 0.10 for Q2 2025 and 0.09 for Q1 2025.